References
- National Institutes of Health evidence-based methodology workshop on polycystic ovary syndrome 3–5 December 2012.
- Pasquali R, Zanotti L, Fanelli F, et al. Defining hyperandrogenism in women with polycystic ovary syndrome: a challenging perspective. J Clin Endocrinol Metab. 2016;101(5):2013–2022.
- Sir-Petermann T, Maliqueo M, Angel B, et al. Maternal serum androgens in pregnant women with polycystic ovarian syndrome: possible implications in prenatal androgenization. Hum Reprod. 2002;17(10):2573–2579.
- Padmanabhan V, Veiga-Lopez A. Sheep models of polycystic ovary syndrome phenotype. Mol Cell Endocrinol. 2013;373(1–2):8–20.
- Abbott DH, Tarantal AF, Dumesic DA. Fetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeys. Am J Primatol. 2009;71(9):776–784.
- Kosut SS, Wood RI, Herbosa-Encarnación C, et al. Prenatal androgens time neuroendocrine puberty in the sheep: effect of testosterone dose. Endocrinology. 1997;138(3):1072–1077.
- Amalfi S, Velez LM, Heber MF, et al. Prenatal hyperandrogenization induces metabolic and endocrine alterations which depend on the levels of testosterone exposure. PLoS One. 2012;7(5):e37658.
- Wang ET, Calderon-Margalit R, Cedars MI, et al. Polycystic ovary syndrome and risk for long-term diabetes and dyslipidemia. Obstet Gynecol. 2011;117(1):6–13.
- Catalano PM, Tyzbir ED, Roman NM, et al. Longitudinal changes in insulin release and insulin resistance in nonobese pregnant women. Am J Obstet Gynecol. 1991;165(6 Pt 1):1667–1672.
- Arshad R, Karim N, Ara Hasan J. Effects of insulin on placental, fetal and maternal outcomes in gestational diabetes mellitus. Pak J Med Sci. 2014;30(2):240–244.
- Picard F, Wanatabe M, Schoonjans K, et al. Progesterone receptor knockout mice have an improved glucose homeostasis secondary to beta -cell proliferation. Proc Natl Acad Sci U S A. 2002;99(24):15644–15648.
- Jackson LM, Timmer KM, Foster DL. Sexual differentiation of the external genitalia and the timing of puberty in the presence of an antiandrogen in sheep. Endocrinology. 2008;149(8):4200–4208.
- National Research Council. Guide for the care and use of laboratory animals. 8th ed. Washington (DC): The National Academies Press; 2011.
- Homburg R. Androgen circle of polycystic ovary syndrome. Hum Reprod. 2009;24(7):1548–1555.
- Nestler JE, Jakubowicz DJ, de Vargas AF, et al. Insulin stimulates testosterone biosynthesis by human thecal cells from women with polycystic ovary syndrome by activating its own receptor and using inositolglycan mediators as the signal transduction system. J Clin Endocrinol Metab. 1998;83(6):2001–2005.
- Abi Salloum B, Veiga-Lopez A, Abbott DH, et al. Developmental programming: exposure to testosterone excess disrupts steroidal and metabolic environment in pregnant sheep. Endocrinology. 2015;156(6):2323–2337.
- Morimoto S, Fernandez-Mejia C, Romero-Navarro G, et al. Testosterone effect on insulin content, messenger ribonucleic acid levels, promoter activity, and secretion in the rat. Endocrinology. 2001;142(4):1442–1447.
- Díaz-Sánchez V, Morimoto S, Morales A, et al. Androgen receptor in the rat pancreas: genetic expression and steroid regulation. Pancreas. 1995;11(3):241–245.
- Ibáñez L, Valls C, Ferrer A, et al. Additive effects of insulin-sensitizing and anti-androgen treatment in young, nonobese women with hyperinsulinism, hyperandrogenism, dyslipidemia, and anovulation. J Clin Endocrinol Metab. 2002;87(6):2870–2874.
- Yannone ME, McCurdy JR, Goldfien A. Plasma progesterone levels in normal pregnancy, labor, and the puerperium: II. Clinical data. Am J Obstet Gynecol. 1968;101(8):1058–1061.
- Boscos CM, Samartzi FC, Lymberopoulos AG, et al. Assessment of progesterone concentration using enzymeimmunoassay, for early pregnancy diagnosis in sheep and goats. Reprod Domest Anim. 2003;38(3):170–174.
- Kleemann DO, Walker SK, Hartwich KM, et al. Fetoplacental growth in sheep administered progesterone during the first three days of pregnancy. Placenta. 2001;22(1):14–23.
- Kim C, Newton KM, Knopp RH. Gestational diabetes and the incidence of type 2 diabetes: a systematic review. Diabetes Care. 2002;25(10):1862–1868.
- Veiga-Lopez A, Steckler TL, Abbott DH, et al. Developmental programming: impact of excess prenatal testosterone on intrauterine fetal endocrine milieu and growth in sheep. Biol Reprod. 2011;84(1):87–96.
- Budge H, Bispham J, Dandrea J, et al. Effect of maternal nutrition on brown adipose tissue and its prolactin receptor status in the fetal lamb. Pediatr Res. 2000;47(6):781–786.
- Fowden AL, Hughes P, Comline RS. The effects of insulin on the growth rate of the sheep fetus during late gestation. Q J Exp Physiol. 1989;74(5):703–714.
- Terauchi Y, Kubota N, Tamemoto H, et al. Insulin effect during embryogenesis determines fetal growth: a possible molecular link between birth weight and susceptibility to type 2 diabetes. Diabetes. 2000;49(1):82–86.
- Philipps AF, Rosenkrantz TS, Clark RM, et al. Effects of fetal insulin deficiency on growth in fetal lambs. Diabetes. 1991;40(1):20–27.